The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.
Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services
Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low-cost treatment option for many people who misuse alcohol and drugs. Nevertheless, inconsistent BT implementation often costs similar to regular outpatient care.
Framework Convention on Tobacco Control (FCTC) was developed by the World Health Organization (WHO) to assist nations in reducing the demand and supply of tobacco. In 2020, 182 nations joined the FCTC, approving to implement the recommended tobacco control measures.
Importance: Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and commonly encountered delays in access to follow-up care.
The 7th international CBC conference brings together academia and industry to exchange developments in behaviour change and digital health to build back better.
This event presents two international smoke-free homes projects and discusses the learning from them for research, practice and policy.
About this event
Professor Kamran Siddiqi, University of York, UK - What can we learn from a large trial of smoke-free home interventions (MCLASS II) in Dhaka Bangladesh?
The Society of Research on Nicotine and Tobacco (SRNT) 2022 Annual Meeting may be a hybrid (part in person, part virtual) or entirely virtual, depending on how things play out in the coming months.
The event will take place in Edinburgh, Scotland from the 2-5th of March 2022.
Abstract submissions will open on July 7, 2021, and will close on August 11, 2021.
Joint Australasian HIV&AIDS and Sexual Health Conferences will once again be hosted in a virtual format between 6 to 9 September, following the success of last year’s inaugural virtual conferences.